PALO ALTO, Calif.

加利福尼亚州帕洛阿尔托

,

，

May 14, 2026

2026年5月14日

/PRNewswire/ -- Transcranial magnetic stimulation (TMS) has been an FDA-cleared therapy for treatment-resistant depression since 2008, but the equipment has historically been too expensive, large, and complex for most clinics to offer.

/PRNewswire/ -- 自2008年以来，经颅磁刺激（TMS）已被美国食品药品监督管理局（FDA）批准为治疗难治性抑郁症的疗法，但该设备一直以来过于昂贵、庞大且复杂，大多数诊所难以提供。

Ampa, co-founded by seminal researcher Jonathan Downar, MD, PhD, has developed a new TMS device that costs $3,000 per month, fits in the trunk of a car, and can be operated after a few hours of training.

Ampa由开创性研究员Jonathan Downar博士（医学博士和哲学博士）共同创立，开发了一种新的TMS设备，每月费用为3000美元，可以放入汽车后备箱，并且经过几小时的培训即可操作。

Continue Reading

继续阅读

A clinician administering treatment with the Ampa One - a portable, camera-guided TMS system designed to make brain stimulation more accessible and easier to deliver (PR Newsfoto/Ampa)

使用Ampa One（一种便携式、摄像引导的TMS系统，旨在使脑刺激更易获取和实施）进行治疗的临床医生（PR Newsfoto/Ampa）

Caption: The Ampa One system, designed for simplicity and portability, fits seamlessly into modern clinics, bringing advanced TMS technology to any setting. (PRNewsfoto/Ampa)

标题：Ampa One系统专为简便和便携性设计，无缝融入现代诊所，将先进的TMS技术带入任何环境。（PRNewsfoto/Ampa）

Today, Ampa announced an oversubscribed financing that will accelerate the rollout of its FDA-cleared Ampa One TMS system, already used by clinics in more than 30 states. Ampa has also secured regulatory approval in Israel, paving the way for commercial launch overseas.

今天，Ampa宣布了一项超额认购的融资，这将加速其已获得FDA批准的Ampa One TMS系统的推广，该系统已被美国30多个州的诊所使用。Ampa还获得了以色列的监管批准，为海外商业发布铺平了道路。

'The Ampa One device is, by far, the simplest way for clinics to add TMS to their offerings,' says Don Vaughn, PhD, CEO and neuroscientist. 'It can be used anywhere, by practically any licensed professional, at a fraction of the typical cost. Demand has doubled every quarter, and this most recent funding will help us meet this accelerating demand.'.

“到目前为止，Ampa One设备是诊所增加TMS服务的最简单方法，”Don Vaughn博士，首席执行官兼神经科学家说道。“它几乎可以在任何地方使用，由几乎任何有执照的专业人员操作，成本仅为典型费用的一小部分。需求每个季度都翻倍，而最近的这笔资金将帮助我们满足这一加速增长的需求。”

This most recent financing was led by a syndicate of investors including Morningside Ventures, Trimera Capital, Neta Foundation, Jake Collective

最近的这次融资由一个投资者财团牵头，包括晨兴创投、Trimera Capital、Neta Foundation、Jake Collective。

,

，

and noted technology investor and author Tim Ferriss, bringing total funding to more than $25 million.

并提到技术投资者和作者蒂姆·费里斯，使总融资额超过2500万美元。

'I've received TMS treatments myself, I've tracked the technology for almost 20 years, and Ampa is poised to offer the iPhone of the field. It's the first device I've seen that could legitimately scale to help millions of people,' said Tim Ferriss. 'I've personally experienced One-Day TMS treatments that have taken my symptoms from a 9 out of 10 in severity to a 1, lasting a minimum of 3-4 months.

“我自己接受过TMS治疗，我追踪这项技术已经将近20年了，而Ampa即将推出该领域的‘iPhone’。这是我见过的第一个能够真正规模化帮助数百万人的设备，”蒂姆·费里斯表示。“我个人体验过一天式的TMS治疗，它将我的症状严重程度从10分中的9分降到了1分，效果至少持续了3到4个月。”

Nothing else I've tried comes close to that durability. It's a glimpse of the future of psychiatry.'.

我尝试过的其他方法都无法与这种持久性相提并论。这是精神病学未来的一瞥。

'We're thrilled to partner with Ampa,' said Owen Muir, MD, Co-Founder of Radial, which operates clinics nationwide that offer Spravato® (esketamine), TMS, neurofeedback, and more. 'The Ampa One is a category-defining product, and we see Ampa emerging as a true platform for next-generation brain medicine therapies.'.

“我们很高兴与Ampa合作，”全国运营提供Spravato®（艾氯胺酮）、TMS、神经反馈等疗法的诊所的Radial公司的联合创始人、医学博士欧文·缪尔表示，“Ampa One是一款定义类别的产品，我们认为Ampa将成为下一代脑医学治疗的真正平台。”

The company continues to see increasing adoption by mental health clinics who appreciate the multi-layered advantages of the Ampa One: portable hardware; a lightweight, hand-holdable coil; camera-guided targeting; pre-printed neuronavigation caps; high-throughput capacity; and affordable subscription pricing..

公司继续看到心理健康诊所对Ampa One的多层优势的认可和采用：便携式硬件、轻量级手持线圈、摄像头引导定位、预印神经导航帽、高通量能力以及价格合理的订阅费用。

'Ampa is bringing innovative, life-changing tools to millions of people navigating significant mental health challenges,' said Melissa Floren Filippone, CEO of Jake Collective, a nonprofit and investment engine dedicated to improving the lives of neurodivergent young people. 'We are excited to be furthering Ampa's critical work with our first impact investment.'.

“安帕正在为数百万面临重大心理健康挑战的人们带来创新的、改变生活的工具，”致力于改善神经多样性年轻人生活的非营利组织和投资机构Jake Collective的首席执行官梅丽莎·弗洛伦·菲利波内说道。“我们非常高兴通过我们的首次影响力投资来进一步推动安帕的关键工作。”

'With breakthrough innovation, Ampa is transforming the landscape and broadening access to care,' added Brian Earthman, MD of Cedar Park TMS, a Beacon Behavioral Partners Clinic.

“通过突破性的创新，Ampa正在改变格局并扩大护理的可及性，”Cedar Park TMS（Beacon Behavioral Partners诊所）的医学博士Brian Earthman补充道。

About Ampa

关于Ampa

Ampa is a neurotechnology company creating practical tools that help people recover their mental health. The FDA-cleared Ampa One system is the most accessible, portable, easy-to-use TMS system available — built by clinicians for clinicians. Learn more and book a demonstration at

Ampa是一家神经技术公司，致力于开发帮助人们恢复心理健康的实用工具。经FDA认证的Ampa One系统是目前最易获取、便携且易于使用的TMS系统——由临床医生为临床医生设计。了解更多信息并预约演示，请访问

www.ampahealth.com

www.ampahealth.com

Media Contact:

媒体联系人:

Itamar Kandel

伊塔马尔·坎德尔

(415) 463-3454

(415) 463-3454

[email protected]

电子邮件地址

SOURCE Ampa

源 Ampa

21

21

%

%

more press release views with

更多新闻稿浏览量与

Request a Demo

请求演示